CODEMA PHARMA
ActiveSummary
The computed 12-month bankruptcy probability of CODEMA PHARMA is 5.9% (elevated). The 2025 annual accounts show equity of €71,289 and a net result of -€32,963. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 30% of 12,686 sector peers (NACE 47, financial year 2025). The company has been active since 2017 and the Belgian Official Gazette contains no insolvency signals. The KBO does carry 1 administrative register entry (see administrative flags).
Group and network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.